Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
This study has been completed.
Sponsor:
Taro Pharmaceuticals USA
Information provided by:
Taro Pharmaceuticals USA
ClinicalTrials.gov Identifier:
NCT00927472
First received: June 23, 2009
Last updated: September 22, 2010
Last verified: September 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |